Today's Information

Provided by: TaiMed Biologics Inc.
SEQ_NO 1 Date of announcement 2022/04/11 Time of announcement 15:00:23
Subject 
 Announcement of Change of the Company's CEO
(President/General Manager)
Date of events 2022/04/11 To which item it meets paragraph 6
Statement 
1.Date of the board of directors resolution or date of occurrence of the
change:2022/04/11
2.Position (Please enter chairperson or president/general manager):
 President/General Manager
3.Name of the previous position holder:James N Chang
4.Resume of the previous position holder:
 Chairperson & CEO/President of TaiMed Biologics Inc.
5.Name of the new position holder:Jimmy Chang
6.Resume of the new position holder:
 Chief Operating Officer of TaiMed Biologics Inc.
7.Circumstances of change (Please enter "resignation", "dismissal",
"term expired" , "job relocation", "severance", "retirement",
"death" or "new appointment"):job relocation
8.Reason for the change:
 In consideration of his approaching the retirement age, current chairman
 and CEO James Chang has decided to step down from the CEO post and  will
 be succeeded by Jimmy Chang, Chief Operating Officer of TaiMed. The change
 has received full approval from the board of directors and will take
 effect on June 1st.  With the completion of its 4X2,000L bioreactor cGMP
 facility, TaiMed announced late last year that, in addition to its core
 drug development, it intends to enter the contract manufacturing (CDMO)
 market for biologics. This new arrangement will facilitate the
 development and management of that important new business venture.
9.Effective date of the new appointment:2022/06/01
10.Any other matters that need to be specified:
 James Chang will continue to serve as the chairperson of the Company.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

TaiMed Biologics Inc. published this content on 11 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 April 2022 07:18:07 UTC.